Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

"First, do no harm" is true for NHS management too.

Willis TA.

BMJ. 2018 Feb 20;360:k656. doi: 10.1136/bmj.k656. No abstract available.

PMID:
29463500
2.

Diffusion mechanism in the sodium-ion battery material sodium cobaltate.

Willis TJ, Porter DG, Voneshen DJ, Uthayakumar S, Demmel F, Gutmann MJ, Roger M, Refson K, Goff JP.

Sci Rep. 2018 Feb 16;8(1):3210. doi: 10.1038/s41598-018-21354-5.

3.

To what extent can behaviour change techniques be identified within an adaptable implementation package for primary care? A prospective directed content analysis.

Glidewell L, Willis TA, Petty D, Lawton R, McEachan RRC, Ingleson E, Heudtlass P, Davies A, Jamieson T, Hunter C, Hartley S, Gray-Burrows K, Clamp S, Carder P, Alderson S, Farrin AJ, Foy R; ASPIRE programme team.

Implement Sci. 2018 Feb 17;13(1):32. doi: 10.1186/s13012-017-0704-7.

4.

Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy.

Sarkozy A, Torelli S, Mein R, Henderson M, Phadke R, Feng L, Sewry C, Ala P, Yau M, Bertoli M, Willis T, Hammans S, Manzur A, Sframeli M, Norwood F, Rakowicz W, Radunovic A, Vaidya SS, Parton M, Walker M, Marino S, Offiah C, Farrugia ME, Mamutse G, Marini-Bettolo C, Wraige E, Beeson D, Lochmüller H, Straub V, Bushby K, Barresi R, Muntoni F.

J Neurol Neurosurg Psychiatry. 2018 Feb 3. pii: jnnp-2017-316956. doi: 10.1136/jnnp-2017-316956. [Epub ahead of print]

PMID:
29437916
5.

Two Cases of Spinal Muscular Atrophy Type II with Eosinophilic Oesophagitis.

Fuller HR, Shorrock HK, Gillingwater TH, Pigott A, Smith V, Kulshrestha R, Sewry CS, Willis TA.

J Neuromuscul Dis. 2017;4(4):357-362. doi: 10.3233/JND-170260.

PMID:
29172006
6.

Kleptopredation: a mechanism to facilitate planktivory in a benthic mollusc.

Willis TJ, Berglöf KTL, McGill RAR, Musco L, Piraino S, Rumsey CM, Fernández TV, Badalamenti F.

Biol Lett. 2017 Nov;13(11). pii: 20170447. doi: 10.1098/rsbl.2017.0447.

PMID:
29093176
7.

Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.

Morís G, Wood L, FernáNdez-Torrón R, González Coraspe JA, Turner C, Hilton-Jones D, Norwood F, Willis T, Parton M, Rogers M, Hammans S, Roberts M, Househam E, Williams M, Lochmüller H, Evangelista T.

Muscle Nerve. 2018 Mar;57(3):380-387. doi: 10.1002/mus.25991. Epub 2017 Nov 7.

PMID:
29053898
8.

The relationship between social capital and potential resilience in individuals.

Hahn D, Willis TL, Christie AR, Mathews SR.

J Emerg Manag. 2017 May/Jun;15(3):189-194. doi: 10.5055/jem.2017.0327.

PMID:
28829531
9.

Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study.

Willis TA, West R, Rushforth B, Stokes T, Glidewell L, Carder P, Faulkner S, Foy R; ASPIRE programme team.

PLoS One. 2017 Jul 13;12(7):e0177949. doi: 10.1371/journal.pone.0177949. eCollection 2017.

10.

Accumulation of autophagosomes confers cytotoxicity.

Button RW, Roberts SL, Willis TL, Hanemann CO, Luo S.

J Biol Chem. 2017 Aug 18;292(33):13599-13614. doi: 10.1074/jbc.M117.782276. Epub 2017 Jul 3.

11.

Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines.

Kahan S, Cuker A, Kushner RF, Maahs J, Recht M, Wadden T, Willis T, Majumdar S, Ungar D, Cooper D.

Haemophilia. 2017 Nov;23(6):812-820. doi: 10.1111/hae.13291. Epub 2017 Jun 21. Review.

PMID:
28636076
12.

Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation.

Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P.

Health Technol Assess. 2017 May;21(27):1-120. doi: 10.3310/hta21270.

13.

Deletion of P2 promoter of GJB1 gene a cause of Charcot-Marie-Tooth disease.

Kulshrestha R, Burton-Jones S, Antoniadi T, Rogers M, Jaunmuktane Z, Brandner S, Kiely N, Manuel R, Willis T.

Neuromuscul Disord. 2017 Aug;27(8):766-770. doi: 10.1016/j.nmd.2017.05.001. Epub 2017 May 4.

PMID:
28601552
14.

The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype.

Schinke C, Hoering A, Wang H, Carlton V, Thanandrarajan S, Deshpande S, Patel P, Molnar G, Susanibar S, Mohan M, Mathur P, Radhakrishnan M, Hoque S, Jo Kamimoto J, Grazziutti M, van Rhee F, Zangari M, Insuasti-Beltran G, Alapat D, Post G, Yaccoby S, Epstein J, Rasche L, Johnson S, Moorhead M, Willis T, Barlogie B, Walker B, Weinhold N, Davies FE, Morgan GJ.

Haematologica. 2017 Aug;102(8):e313-e316. doi: 10.3324/haematol.2017.165217. Epub 2017 May 18. No abstract available.

15.

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald CM, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC.

Contemp Clin Trials. 2017 Jul;58:34-39. doi: 10.1016/j.cct.2017.04.008. Epub 2017 Apr 24.

PMID:
28450193
16.

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.

Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P.

Pilot Feasibility Stud. 2017 Mar 27;3:16. doi: 10.1186/s40814-017-0132-0. eCollection 2017.

17.

Tambora and the mackerel year: Phenology and fisheries during an extreme climate event.

Alexander KE, Leavenworth WB, Willis TV, Hall C, Mattocks S, Bittner SM, Klein E, Staudinger M, Bryan A, Rosset J, Carr BH, Jordaan A.

Sci Adv. 2017 Jan 18;3(1):e1601635. doi: 10.1126/sciadv.1601635. eCollection 2017 Jan.

18.

Partnering With a Family Advisor to Improve Communication in a Pediatric Intensive Care Unit.

Czulada L, Leino P, Willis TS.

Am J Med Qual. 2016 Nov;31(6):520-525. Epub 2015 Aug 20.

PMID:
26294698
19.

Reduction of Healthcare-Associated Infections by Exceeding High Compliance with Hand Hygiene Practices.

Sickbert-Bennett EE, DiBiase LM, Willis TM, Wolak ES, Weber DJ, Rutala WA.

Emerg Infect Dis. 2016 Sep;22(9):1628-30. doi: 10.3201/eid2209.151440.

20.

Using the Theoretical Domains Framework (TDF) to understand adherence to multiple evidence-based indicators in primary care: a qualitative study.

Lawton R, Heyhoe J, Louch G, Ingleson E, Glidewell L, Willis TA, McEachan RR, Foy R; ASPIRE programme.

Implement Sci. 2016 Aug 8;11:113. doi: 10.1186/s13012-016-0479-2.

21.

Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.

Willis TA, Wood CL, Hudson J, Polvikoski T, Barresi R, Lochmüller H, Bushby K, Straub V.

Clin Genet. 2016 Aug;90(2):166-70. doi: 10.1111/cge.12695. Epub 2016 Jan 8.

PMID:
27409453
22.

The impact of HENRY on parenting and family lifestyle: A national service evaluation of a preschool obesity prevention programme.

Willis TA, Roberts KP, Berry TM, Bryant M, Rudolf MC.

Public Health. 2016 Jul;136:101-8. doi: 10.1016/j.puhe.2016.04.006. Epub 2016 May 13.

PMID:
27184820
23.

A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness.

Willis T, Hedberg-Oldfors C, Alhaswani Z, Kulshrestha R, Sewry C, Oldfors A.

J Neurol. 2016 Jul;263(7):1427-33. doi: 10.1007/s00415-016-8154-8. Epub 2016 May 13.

PMID:
27177998
24.

Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.

Lukacs Z, Nieves Cobos P, Wenninger S, Willis TA, Guglieri M, Roberts M, Quinlivan R, Hilton-Jones D, Evangelista T, Zierz S, Schlotter-Weigel B, Walter MC, Reilich P, Klopstock T, Deschauer M, Straub V, Müller-Felber W, Schoser B.

Neurology. 2016 Jul 19;87(3):295-8. doi: 10.1212/WNL.0000000000002758. Epub 2016 May 11.

25.

Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry.

Evangelista T, Wood L, Fernandez-Torron R, Williams M, Smith D, Lunt P, Hudson J, Norwood F, Orrell R, Willis T, Hilton-Jones D, Rafferty K, Guglieri M, Lochmüller H.

J Neurol. 2016 Jul;263(7):1401-8. doi: 10.1007/s00415-016-8132-1. Epub 2016 May 9.

26.

Action to Support Practices Implement Research Evidence (ASPIRE): protocol for a cluster-randomised evaluation of adaptable implementation packages targeting 'high impact' clinical practice recommendations in general practice.

Willis TA, Hartley S, Glidewell L, Farrin AJ, Lawton R, McEachan RR, Ingleson E, Heudtlass P, Collinson M, Clamp S, Hunter C, Ward V, Hulme C, Meads D, Bregantini D, Carder P, Foy R; ASPIRE programme.

Implement Sci. 2016 Feb 29;11:25. doi: 10.1186/s13012-016-0387-5.

27.

Optimizing primary care research participation: a comparison of three recruitment methods in data-sharing studies.

Lord PA, Willis TA, Carder P, West RM, Foy R.

Fam Pract. 2016 Apr;33(2):200-4. doi: 10.1093/fampra/cmw003. Epub 2016 Feb 27.

PMID:
26921610
28.

Developing 'high impact' guideline-based quality indicators for UK primary care: a multi-stage consensus process.

Rushforth B, Stokes T, Andrews E, Willis TA, McEachan R, Faulkner S, Foy R.

BMC Fam Pract. 2015 Oct 28;16:156. doi: 10.1186/s12875-015-0350-6.

29.

Reef Fishes at All Trophic Levels Respond Positively to Effective Marine Protected Areas.

Soler GA, Edgar GJ, Thomson RJ, Kininmonth S, Campbell SJ, Dawson TP, Barrett NS, Bernard AT, Galván DE, Willis TJ, Alexander TJ, Stuart-Smith RD.

PLoS One. 2015 Oct 13;10(10):e0140270. doi: 10.1371/journal.pone.0140270. eCollection 2015.

30.

Patient attitudes towards prenatal diagnostic testing for inherited retinal disease.

Ahmed K, Ahmed M, Potrata B, Willis TA, Grant HL, Allsop MJ, Hewison J, Downey L, Gale R, McKibbin M.

Prenat Diagn. 2015 Sep;35(9):913-8. doi: 10.1002/pd.4644. Epub 2015 Jul 16.

PMID:
26126503
31.

Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.

Figueroa-Bonaparte S, Hudson J, Barresi R, Polvikoski T, Williams T, Töpf A, Harris E, Hilton-Jones D, Petty R, Willis TA, Longman C, Dougan CF, Parton MJ, Hanna MG, Quinlivan R, Farrugia ME, Guglieri M, Bushby K, Straub V, Lochmüller H, Evangelista T.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1. doi: 10.1136/jnnp-2015-310362. Epub 2015 Jun 23. No abstract available.

32.

Anxiety Disorders and Sleep in Children and Adolescents.

Willis TA, Gregory AM.

Sleep Med Clin. 2015 Jun;10(2):125-31. doi: 10.1016/j.jsmc.2015.02.002. Epub 2015 Mar 7. Review.

PMID:
26055860
33.

THE INFLUENCE OF VITREOMACULAR ADHESION ON OUTCOMES AFTER AFLIBERCEPT THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

McKibbin MA, Suter CA, Willis TA.

Retina. 2015 Oct;35(10):1951-6. doi: 10.1097/IAE.0000000000000587.

PMID:
25932561
34.

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.

Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Steinberg SM, Chen CC, Zheng J, Willis TD, Faham M, Wilson WH.

Lancet Oncol. 2015 May;16(5):541-9. doi: 10.1016/S1470-2045(15)70106-3. Epub 2015 Apr 1. Erratum in: Lancet Oncol. 2015 May;16(5):e199.

35.

Willingness to pay for genetic testing for inherited retinal disease.

Tubeuf S, Willis TA, Potrata B, Grant H, Allsop MJ, Ahmed M, Hewison J, McKibbin M.

Eur J Hum Genet. 2015 Mar;23(3):285-91. doi: 10.1038/ejhg.2014.111. Epub 2014 Jun 11.

36.

Successful implementation of standardized multidisciplinary bedside rounds, including daily goals, in a pediatric ICU.

Seigel J, Whalen L, Burgess E, Joyner BL Jr, Purdy A, Saunders R, Thompson L, Yip T, Willis TS.

Jt Comm J Qual Patient Saf. 2014 Feb;40(2):83-90. No abstract available.

PMID:
24716331
37.

Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study.

Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmuller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V.

PLoS One. 2014 Feb 28;9(2):e90377. doi: 10.1371/journal.pone.0090377. eCollection 2014.

38.

Combining genetic and demographic information to prioritize conservation efforts for anadromous alewife and blueback herring.

Palkovacs EP, Hasselman DJ, Argo EE, Gephard SR, Limburg KE, Post DM, Schultz TF, Willis TV.

Evol Appl. 2014 Feb;7(2):212-26. doi: 10.1111/eva.12111. Epub 2013 Oct 2.

39.

Global conservation outcomes depend on marine protected areas with five key features.

Edgar GJ, Stuart-Smith RD, Willis TJ, Kininmonth S, Baker SC, Banks S, Barrett NS, Becerro MA, Bernard AT, Berkhout J, Buxton CD, Campbell SJ, Cooper AT, Davey M, Edgar SC, Försterra G, Galván DE, Irigoyen AJ, Kushner DJ, Moura R, Parnell PE, Shears NT, Soler G, Strain EM, Thomson RJ.

Nature. 2014 Feb 13;506(7487):216-20. doi: 10.1038/nature13022. Epub 2014 Feb 5.

PMID:
24499817
40.

Current understanding of genetics and genetic testing and information needs and preferences of adults with inherited retinal disease.

McKibbin M, Ahmed M, Allsop MJ, Downey L, Gale R, Grant HL, Potrata B, Willis TA, Hewison J.

Eur J Hum Genet. 2014 Sep;22(9):1058-62. doi: 10.1038/ejhg.2013.296. Epub 2014 Jan 8.

41.

Integrating abundance and functional traits reveals new global hotspots of fish diversity.

Stuart-Smith RD, Bates AE, Lefcheck JS, Duffy JE, Baker SC, Thomson RJ, Stuart-Smith JF, Hill NA, Kininmonth SJ, Airoldi L, Becerro MA, Campbell SJ, Dawson TP, Navarrete SA, Soler GA, Strain EM, Willis TJ, Edgar GJ.

Nature. 2013 Sep 26;501(7468):539-42. doi: 10.1038/nature12529.

PMID:
24067714
42.

Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study.

Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmüller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V.

PLoS One. 2013 Aug 14;8(8):e70993. doi: 10.1371/journal.pone.0070993. eCollection 2013.

43.

Preventing child obesity: a long-term evaluation of the HENRY approach.

Brown RE, Willis TA, Aspinall N, Candida H, George J, Rudolf MC.

Community Pract. 2013 Jul;86(7):23-7.

PMID:
23914474
44.

Combating child obesity: impact of HENRY on parenting and family lifestyle.

Willis TA, George J, Hunt C, Roberts KP, Evans CE, Brown RE, Rudolf MC.

Pediatr Obes. 2014 Oct;9(5):339-50. doi: 10.1111/j.2047-6310.2013.00183.x. Epub 2013 Jul 2.

PMID:
23818487
45.

Understanding of and attitudes to genetic testing for inherited retinal disease: a patient perspective.

Willis TA, Potrata B, Ahmed M, Hewison J, Gale R, Downey L, McKibbin M.

Br J Ophthalmol. 2013 Sep;97(9):1148-54. doi: 10.1136/bjophthalmol-2013-303434. Epub 2013 Jun 28.

46.

Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I.

Hollingsworth KG, Willis TA, Bates MG, Dixon BJ, Lochmüller H, Bushby K, Bourke J, MacGowan GA, Straub V.

Eur J Heart Fail. 2013 Sep;15(9):986-94. doi: 10.1093/eurjhf/hft057. Epub 2013 Apr 10.

47.

Catastrophizing and poor sleep quality in early adolescent females.

Noone DM, Willis TA, Cox J, Harkness F, Ogilvie J, Forbes E, Sterr A, Gregory AM.

Behav Sleep Med. 2014;12(1):41-52. doi: 10.1080/15402002.2013.764528. Epub 2013 Mar 8.

PMID:
23473103
48.

Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature.

Willis MS, Cairns BA, Purdy A, Bortsov AV, Jones SW, Ortiz-Pujols SM, Willis TM, Joyner BL Jr.

Int J Burns Trauma. 2013;3(1):1-8. Epub 2013 Jan 24.

49.

Monozygotic twin differences in non-shared environmental factors associated with chronotype.

Barclay NL, Eley TC, Parsons MJ, Willis TA, Gregory AM.

J Biol Rhythms. 2013 Feb;28(1):51-61. doi: 10.1177/0748730412468698.

PMID:
23382591
50.

Presymptomatic late-onset Pompe disease identified by the dried blood spot test.

Wagner M, Chaouch A, Müller JS, Polvikoski T, Willis TA, Sarkozy A, Eagle M, Bushby K, Straub V, Lochmüller H.

Neuromuscul Disord. 2013 Jan;23(1):89-92. doi: 10.1016/j.nmd.2012.09.004. Epub 2012 Oct 10.

PMID:
23062590

Supplemental Content

Loading ...
Support Center